ENTRI has extensive experience in commercializing orphan drugs across (Northern) Europe. We build the optimal launch strategy across the region, by country and successfully manage the execution. We custom build our team based on your unique needs; ensuring a targeted and cost-efficient approach.
| Website | https://entriaccess2rare.eu/ |
| Employees | 9 (2 on RocketReach) |
| Industry | Business Consulting and Services |
Looking for a particular ENTRI Access2Rare employee's phone or email?
Jari Pajasmaa is the Co-founder ENTRI of ENTRI Access2Rare.
2 people are employed at ENTRI Access2Rare.